Behavioural and physiological measures of the effects of dopamine on attention in Parkinson*s disease

Completed

• Conditions: Parkinson's disease; PD; 10028037

• Registration Number: NL-OMON34140
• Lead Sponsor: Vrije Universiteit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 72

Inclusion Criteria

Diagnosis of idiopathic PD following UK Brain Bank criteria in Hoehn and Yahr stages2-3
40-75 years old
informed consent
On DA replacement therapy

Exclusion Criteria

psychotropic medication other than DA therapy (at least 4 weeks off medication)
major somatic disorder or known psychiatric diagnosis
Dementia (MMSE <23)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Outcome parameters are: behavioural measures of response latency and accuracy<br /><br>and non-invasive electrophysiological measures in the form of event-related<br /><br>potentials. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>